Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 261

    1.

    Valacyclovir Pharmacokinetics and Exploratory Pharmacodynamics in Young Adults With Epstein-Barr Virus Infectious Mononucleosis.

    Vezina HE, Balfour HH Jr, Weller DR, Anderson BJ, Brundage R.

    J Clin Pharmacol. 2009 Nov 6. [Epub ahead of print]PMID: 19897764 [PubMed - as supplied by publisher]Related articles

    2.
    3.

    Coinfection alters the playing field: herpesviruses induce acyclovir to inhibit HIV.

    Stapleton JT, Balfour HH Jr.

    Cell Host Microbe. 2008 Sep 11;4(3):194-5.PMID: 18779044 [PubMed - indexed for MEDLINE]Related articles

    4.

    Epstein-Barr virus vaccine for the prevention of infectious mononucleosis--and what else?

    Balfour HH Jr.

    J Infect Dis. 2007 Dec 15;196(12):1724-6. No abstract available. PMID: 18190249 [PubMed - indexed for MEDLINE]Related articles

    5.

    Multicenter comparison of different real-time PCR assays for quantitative detection of Epstein-Barr virus.

    Hayden RT, Hokanson KM, Pounds SB, Bankowski MJ, Belzer SW, Carr J, Diorio D, Forman MS, Joshi Y, Hillyard D, Hodinka RL, Nikiforova MN, Romain CA, Stevenson J, Valsamakis A, Balfour HH Jr; U.S. EBV Working Group.

    J Clin Microbiol. 2008 Jan;46(1):157-63. Epub 2007 Nov 7.PMID: 17989187 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    A virologic pilot study of valacyclovir in infectious mononucleosis.

    Balfour HH Jr, Hokanson KM, Schacherer RM, Fietzer CM, Schmeling DO, Holman CJ, Vezina HE, Brundage RC.

    J Clin Virol. 2007 May;39(1):16-21. Epub 2007 Mar 21.PMID: 17369082 [PubMed - indexed for MEDLINE]Related articles

    7.

    An isocratic liquid chromatography method for determining HIV non-nucleoside reverse transcriptase inhibitor and protease inhibitor concentrations in human plasma.

    Weller DR, Brundage RC, Balfour HH Jr, Vezina HE.

    J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Apr 1;848(2):369-73. Epub 2006 Nov 1.PMID: 17081812 [PubMed - indexed for MEDLINE]Related articles

    8.

    A randomized crossover study to determine bioequivalence of generic and brand name nevirapine, zidovudine, and lamivudine in HIV-negative women in India.

    Vezina HE, Henry K, Ravindran GD, Kurpad AV, Raj TD, Fox K, Weller D, Brundage RC, Cavert W, Balfour HH Jr.

    J Acquir Immune Defic Syndr. 2006 Feb 1;41(2):131-6.PMID: 16394842 [PubMed - indexed for MEDLINE]Related articles

    9.

    A prospective clinical study of Epstein-Barr virus and host interactions during acute infectious mononucleosis.

    Balfour HH Jr, Holman CJ, Hokanson KM, Lelonek MM, Giesbrecht JE, White DR, Schmeling DO, Webb CH, Cavert W, Wang DH, Brundage RC.

    J Infect Dis. 2005 Nov 1;192(9):1505-12. Epub 2005 Sep 26.PMID: 16206064 [PubMed - indexed for MEDLINE]Related articles

    10.

    Alterations in the C-terminal region of the HIV-1 accessory gene vpr do not confer clinical advantage to subjects receiving nucleoside antiretroviral therapy.

    Cavert W, Webb CH, Balfour HH Jr.

    J Infect Dis. 2004 Jun 15;189(12):2181-4. Epub 2004 May 21.PMID: 15181564 [PubMed - indexed for MEDLINE]Related articles

    11.

    Detection of antiretroviral resistance in HIV-1.

    Cavert W, Balfour HH Jr.

    Clin Lab Med. 2003 Dec;23(4):915-28. Review.PMID: 14711099 [PubMed - indexed for MEDLINE]Related articles

    12.

    Intermittent administration of high-dose stavudine to nucleoside-experienced individuals infected with HIV-1.

    Acosta EP, Balfour HH Jr.

    J Acquir Immune Defic Syndr. 2003 Jul 1;33(3):343-8.PMID: 12843745 [PubMed - indexed for MEDLINE]Related articles

    13.

    Ganciclovir-resistant cytomegalovirus encephalitis in a bone marrow transplant recipient.

    Julin JE, van Burik JH, Krivit W, Webb C, Holman CJ, Clark HB, Balfour HH Jr.

    Transpl Infect Dis. 2002 Dec;4(4):201-6.PMID: 12535263 [PubMed - indexed for MEDLINE]Related articles

    14.

    Lymphocyte mitochondrial biomarkers in asymptomatic HIV-1-infected individuals treated with nucleoside reverse transcriptase inhibitors.

    Henry K, Erice A, Balfour HH Jr, Schmeling M, Berthiaume J, Wallace K.

    AIDS. 2002 Dec 6;16(18):2485-7. No abstract available. PMID: 12461427 [PubMed - indexed for MEDLINE]Related articles

    15.

    Predictive value of HIV-1 viral load on risk for opportunistic infection.

    Swindells S, Evans S, Zackin R, Goldman M, Haubrich R, Filler SG, Balfour HH Jr; AIDS Clinical Trial Group 722 Study Team.

    J Acquir Immune Defic Syndr. 2002 Jun 1;30(2):154-8.PMID: 12045677 [PubMed - indexed for MEDLINE]Related articles

    16.

    Controlled trial of acyclovir for chickenpox evaluating time of initiation and duration of therapy and viral resistance.

    Balfour HH Jr, Edelman CK, Anderson RS, Reed NV, Slivken RM, Marmor LH, Dix L, Aeppli D, Talarico CL.

    Pediatr Infect Dis J. 2001 Oct;20(10):919-26.PMID: 11642624 [PubMed - indexed for MEDLINE]Related articles

    17.

    Acyclovir for treatment of postherpetic neuralgia: efficacy and pharmacokinetics.

    Acosta EP, Balfour HH Jr.

    Antimicrob Agents Chemother. 2001 Oct;45(10):2771-4.PMID: 11557467 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Analysis of HIV-1 reverse transcriptase and protease sequences in paired plasma and lymphoid tissue specimens from HIV-1 infected individuals.

    Erice A, Li W, Balfour HH Jr, Boies LR Jr, Melroe H, Henry K.

    AIDS. 2001 May 4;15(7):831-6.PMID: 11399955 [PubMed - indexed for MEDLINE]Related articles

    19.

    Effect of lamivudine in HIV-infected persons with prior exposure to zidovudine/didanosine or zidovudine/zalcitabine.

    Albrecht MA, Hughes MD, Liou SH, Katzenstein DA, Murphy R, Balfour HH, Para MF, Valdez H, Hammer SM; ACTG 303 Study Team.

    AIDS Res Hum Retroviruses. 2000 Sep 20;16(14):1337-44.PMID: 11018853 [PubMed - indexed for MEDLINE]Related articles

    20.

    Semen and serum pharmacokinetics of zidovudine and zidovudine-glucuronide in men with HIV-1 infection.

    Anderson PL, Noormohamed SE, Henry K, Brundage RC, Balfour HH Jr, Fletcher CV.

    Pharmacotherapy. 2000 Aug;20(8):917-22.PMID: 10939552 [PubMed - indexed for MEDLINE]Related articles

    21.

    Antiviral drugs.

    Balfour HH Jr.

    N Engl J Med. 1999 Apr 22;340(16):1255-68. Review. No abstract available. PMID: 10210711 [PubMed - indexed for MEDLINE]Related articles

    23.

    Atovaquone compared with dapsone for the prevention of Pneumocystis carinii pneumonia in patients with HIV infection who cannot tolerate trimethoprim, sulfonamides, or both. Community Program for Clinical Research on AIDS and the AIDS Clinical Trials Group.

    El-Sadr WM, Murphy RL, Yurik TM, Luskin-Hawk R, Cheung TW, Balfour HH Jr, Eng R, Hooton TM, Kerkering TM, Schutz M, van der Horst C, Hafner R.

    N Engl J Med. 1998 Dec 24;339(26):1889-95.PMID: 9862944 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    A randomized, controlled, double-blind study comparing the survival benefit of four different reverse transcriptase inhibitor therapies (three-drug, two-drug, and alternating drug) for the treatment of advanced AIDS. AIDS Clinical Trial Group 193A Study Team.

    Henry K, Erice A, Tierney C, Balfour HH Jr, Fischl MA, Kmack A, Liou SH, Kenton A, Hirsch MS, Phair J, Martinez A, Kahn JO.

    J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Dec 1;19(4):339-49.PMID: 9833742 [PubMed - indexed for MEDLINE]Related articles

    25.

    Concentration-controlled zidovudine therapy.

    Fletcher CV, Acosta EP, Henry K, Page LM, Gross CR, Kawle SP, Remmel RP, Erice A, Balfour HH Jr.

    Clin Pharmacol Ther. 1998 Sep;64(3):331-8.PMID: 9757157 [PubMed - indexed for MEDLINE]Related articles

    26.

    Ganciclovir susceptibilities and analysis of UL97 region in cytomegalovirus (CMV) isolates from bone marrow recipients with CMV disease after antiviral prophylaxis.

    Erice A, Borrell N, Li W, Miller WJ, Balfour HH Jr.

    J Infect Dis. 1998 Aug;178(2):531-4.PMID: 9697737 [PubMed - indexed for MEDLINE]Related articles

    27.

    Phenotypic and genotypic characterization of acyclovir-resistant herpes simplex viruses from immunocompromised patients.

    Gaudreau A, Hill E, Balfour HH Jr, Erice A, Boivin G.

    J Infect Dis. 1998 Aug;178(2):297-303.PMID: 9697707 [PubMed - indexed for MEDLINE]Related articles

    28.

    A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.

    Hammer SM, Squires KE, Hughes MD, Grimes JM, Demeter LM, Currier JS, Eron JJ Jr, Feinberg JE, Balfour HH Jr, Deyton LR, Chodakewitz JA, Fischl MA.

    N Engl J Med. 1997 Sep 11;337(11):725-33.PMID: 9287227 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Pharmacokinetics of hyperimmune anti-human immunodeficiency virus immunoglobulin in persons with AIDS.

    Fletcher CV, Goodroad BK, Cummins LM, Henry K, Balfour HH Jr, Rhame FS.

    Antimicrob Agents Chemother. 1997 Jul;41(7):1571-4.PMID: 9210687 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Pharmacokinetics and safety of concentration-controlled oral zidovudine therapy.

    Acosta EP, Henry K, Page LM, Erice A, Balfour HH Jr, Fletcher CV.

    Pharmacotherapy. 1997 May-Jun;17(3):424-30.PMID: 9165546 [PubMed - indexed for MEDLINE]Related articles

    31.

    Antiviral susceptibilities and analysis of UL97 and DNA polymerase sequences of clinical cytomegalovirus isolates from immunocompromised patients.

    Erice A, Gil-Roda C, Pérez JL, Balfour HH Jr, Sannerud KJ, Hanson MN, Boivin G, Chou S.

    J Infect Dis. 1997 May;175(5):1087-92.PMID: 9129070 [PubMed - indexed for MEDLINE]Related articles

    32.

    Recombinant human erythropoietin for treatment of anemia in persons with AIDS not receiving zidovudine.

    Balfour HH Jr.

    Int J Antimicrob Agents. 1997;8(3):189-92.PMID: 18611800 [PubMed - in process]Related articles

    33.

    [Treatment of varicella]

    Balfour HH.

    Presse Med. 1997 Jan;26 Suppl 1:2-3. Review. French. No abstract available. PMID: 9082438 [PubMed - indexed for MEDLINE]Related articles

    34.

    Effect of foscarnet on quantities of cytomegalovirus and human immunodeficiency virus in blood of persons with AIDS.

    Balfour HH Jr, Fletcher CV, Erice A, Henry WK, Acosta EP, Smith SA, Holm MA, Boivin G, Shepp DH, Crumpacker CS, Eaton CA, Martin-Munley SS.

    Antimicrob Agents Chemother. 1996 Dec;40(12):2721-6.PMID: 9124829 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Quantitative image analysis of HIV-1 infection in lymphoid tissue.

    Haase AT, Henry K, Zupancic M, Sedgewick G, Faust RA, Melroe H, Cavert W, Gebhard K, Staskus K, Zhang ZQ, Dailey PJ, Balfour HH Jr, Erice A, Perelson AS.

    Science. 1996 Nov 8;274(5289):985-9.PMID: 8875941 [PubMed - indexed for MEDLINE]Related articles

    36.

    Variability in zidovudine serum concentrations.

    Fletcher CV, Balfour HH Jr.

    Pharmacotherapy. 1996 Nov-Dec;16(6):1154-8.PMID: 8947989 [PubMed - indexed for MEDLINE]Related articles

    37.

    Prevention of cytomegalovirus disease.

    Balfour HH Jr.

    Int J Antimicrob Agents. 1996 Oct;7(4):283-5.PMID: 18611770 [PubMed - in process]Related articles

    38.

    Antiviral drug development: the road less taken.

    Balfour HH Jr.

    Ann Pharmacother. 1996 Sep;30(9):964-6. No abstract available. PMID: 8876857 [PubMed - indexed for MEDLINE]Related articles

    39.

    Strategies for control of zidovudine concentrations in serum.

    Noormohamed SE, Henry WK, Rhame FS, Balfour HH Jr, Fletcher CV.

    Antimicrob Agents Chemother. 1995 Dec;39(12):2792-7.PMID: 8593022 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    The effect of cimetidine and ranitidine administration with zidovudine.

    Fletcher CV, Henry WK, Noormohamed SE, Rhame FS, Balfour HH Jr.

    Pharmacotherapy. 1995 Nov-Dec;15(6):701-8.PMID: 8602376 [PubMed - indexed for MEDLINE]Related articles

    41.

    Evaluation of CMV-vue antigenemia assay for rapid detection of cytomegalovirus in mixed-leukocyte blood fractions.

    Erice A, Holm MA, Sanjuan MV, Dunn DL, Gill PC, Balfour HH Jr.

    J Clin Microbiol. 1995 Apr;33(4):1014-5.PMID: 7790426 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Congenital cytomegalovirus infection as a result of nonprimary cytomegalovirus disease in a mother with acquired immunodeficiency syndrome.

    Schwebke K, Henry K, Balfour HH Jr, Olson D, Crane RT, Jordan MC.

    J Pediatr. 1995 Feb;126(2):293-5.PMID: 7844681 [PubMed - indexed for MEDLINE]Related articles

    43.

    Acyclovir for childhood chickenpox. No reason not to treat.

    Balfour HH Jr.

    BMJ. 1995 Jan 14;310(6972):109-10. No abstract available. PMID: 7833701 [PubMed - indexed for MEDLINE]Related articlesFree article

    44.

    Cytomegalovirus retinitis in persons with AIDS. Selecting therapy for a sight-threatening disease.

    Balfour HH Jr.

    Postgrad Med. 1995 Jan;97(1):109-13, 117-8. Review.PMID: 7816708 [PubMed - indexed for MEDLINE]Related articles

    45.

    Prevalence of oral lesions in symptomatic and asymptomatic HIV patients.

    Little JW, Melnick SL, Rhame FS, Balfour HH Jr, Decher L, Rhodus NL, Merry JW, Walker PO, Miller CE, Volberding P.

    Gen Dent. 1994 Sep-Oct;42(5):446-50. No abstract available. PMID: 7489878 [PubMed - indexed for MEDLINE]Related articles

    46.

    The duration of zidovudine benefit in persons with asymptomatic HIV infection. Prolonged evaluation of protocol 019 of the AIDS Clinical Trials Group.

    Volberding PA, Lagakos SW, Grimes JM, Stein DS, Balfour HH Jr, Reichman RC, Bartlett JA, Hirsch MS, Phair JP, Mitsuyasu RT, et al.

    JAMA. 1994 Aug 10;272(6):437-42.PMID: 7913730 [PubMed - indexed for MEDLINE]Related articles

    47.

    Phenotypic and genotypic characterization of acyclovir-resistant varicella-zoster viruses isolated from persons with AIDS.

    Boivin G, Edelman CK, Pedneault L, Talarico CL, Biron KK, Balfour HH Jr.

    J Infect Dis. 1994 Jul;170(1):68-75.PMID: 8014522 [PubMed - indexed for MEDLINE]Related articles

    48.

    Use of semiquantitative human immunodeficiency virus type 1 culture to guide therapy in a premature infant.

    Toltzis P, Marx CM, Balfour HH Jr, Jackson JB.

    Am J Clin Pathol. 1994 Jun;101(6):753-5.PMID: 8209864 [PubMed - indexed for MEDLINE]Related articles

    49.

    Serum p24 antigen level as an intermediate end point in clinical trials of zidovudine in people infected with human immunodeficiency virus type 1. Aids Clinical Trials Group Virology Laboratories.

    DeGruttola V, Beckett LA, Coombs RW, Arduino JM, Balfour HH Jr, Rasheed S, Hollinger FB, Fischl MA, Volberding P.

    J Infect Dis. 1994 Apr;169(4):713-21.PMID: 8133085 [PubMed - indexed for MEDLINE]Related articles

    50.

    A prospective randomized study of acyclovir versus ganciclovir plus human immune globulin prophylaxis of cytomegalovirus infection after solid organ transplantation.

    Dunn DL, Gillingham KJ, Kramer MA, Schmidt WJ, Erice A, Balfour HH Jr, Gores PF, Gruessner RW, Matas AJ, Payne WD, et al.

    Transplantation. 1994 Mar 27;57(6):876-84.PMID: 8154035 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...